The results of DNA analysis for the specific mutation of myotonic dystrophy are reported in eight pregnancies (two studied retrospectively) in six families. Four results were normal; in the other four, large DNA expansions were found, comparable to the range seen in severely affected children with congenital onset of the disorder. The results agreed with those obtained by linked DNA markers in the six cases where they were available. We conclude that specific molecular prenatal diagnosis of myotonic dystrophy is feasible, and that an abnormal result may also give a guide to possible severity, though this should be interpreted with caution until greater experience is available. (J Med Genet 1992;29:785-8) 
Results
The overall results of the study are summarised in the table. Of the eight pregnancies analysed (two retrospectively on stored DNA from earlier chorion biopsies), four were predicted to be affected, each with a clear expanded DNA sequence, while the remaining four samples showed no abnormality using restriction enzyme EcoRI.
Case reports FAMILY 1 This family from Israel has already been mentioned briefly in a previous report.9 Two sisters, both moderately affected with myotonic dystrophy from late teenage years, requested prenatal diagnosis in a total of four pregnancies, the last occurring shortly after detection of the unstable CTG sequence. The first pregnancy of the older sister had ended in the neonatal death of a congenitally affected child, an event which led to the diagnosis of myotonic dystrophy in the mother and other family members. In her subsequent two pregnancies prenatal diagnosis was requested and a low risk was predicted in both by the use of linked DNA markers on DNA from chorion biopsies. Healthy children without signs of myotonic dystrophy were subsequently born.
The younger sister later requested prenatal diagnosis in her first pregnancy; a high risk was predicted by linked markers and the pregnancy was terminated. She again requested prenatal diagnosis in her second pregnancy, the CVS sample being received soon after the recognition of the CTG unstable sequence in myotonic dystrophy and before we had experience of its use in a diagnostic situation.
After considerable discussion it was decided to rely primarily on genetic linkage rather than on the hitherto untried specific mutation test; the closely linked marker D19S63 again predicted a high risk and the pregnancy was terminated on the basis of this report. DNA from this CVS sample was simultaneously analysed for the unstable sequence ( fig 1) along with DNA from family members and residual CVS DNA from the previous high risk pregnancy. DNA available from one of the two low risk pregnancies of the sister was tested separately.
It can be seen that both high risk pregnancies show an abnormal band expanded by around 3 kb, in the range found to be associated with severe disease9; the two mothers show abnormal bands of moderate size, while the affected grandfather also shows a small DNA expansion. No abnormal band was seen in the CVS sample from the pregnancy predicted to be at low risk (not shown in fig 1) . FAMILY 2 In this British family, referred from Birmingham by Dr Ian Glass, the affected mother already had two congenitally affected children and requested prenatal diagnosis in her third pregnancy. The mother shows a moderate DNA expansion, while large expanded bands are present in the two congenitally affected children. The CVS sample shows a single 9 kb band, suggesting the fetus has received this allele from both parents ( fig 2) . There is no evidence of an expanded fragment. Linked markers also predicted a low risk and the pregnancy continues. FAMILY 3 This family was referred by Dr M Zatz, Sao Paulo, Brazil. The healthy wife of a moderately affected man with myotonic dystrophy requested prenatal diagnosis and underwent chorion biopsy at 91 weeks of pregnancy. Samples were sent by air to Cardiff and the results are shown in fig 3. Both the proband and his affected brother show an abnormal expanded band, while the unaffected wife of the proband is homozygous for a normal 10 kb band. The fetus is heterozygous with normal 9 and 10 kb bands; the fact that it is the 9 kb band that has been received from the affected father makes it even less likely that the fetus would be affected, since in all cases studied so far, the expansion has been of a 10 kb band.6 FAMILY 4 In this British family the affected mother had already given birth to a severely affected child, and also had an affected sister and father. All affected members showed an expanded fragment, largest in the severely affected child. The CVS sample taken at 11 weeks' gestation showed an expanded band slightly larger than that of the severely affected sib. Linked markers also predicted an affected fetus and termination was carried out. FAMILY 5 In this family, the affected mother had previously undergone prenatal diagnosis using linked probes (D19S63), the outcome of which The four abnormal CV samples detected in three families all showed large DNA expansions in the range found most frequently in patients with congenital onset, and not encountered in mild or minimal disease.9 10 This is consistent with the fact that in the families concerned the mother was the affected parent; in two (families 4 and 6) the mother had previously had a seriously affected child, while in the other (family 1) the mother's sister, who was similarly affected, had lost a child with congenital myotonic dystrophy.
The possibility of predicting phenotype as well as genotype in prenatal diagnosis by DNA analysis is important, especially in an exceptionally variable disorder such as myotonic dystrophy, where subjects may be mildly or severely affected. Severity may be as important as numerical risk in determining parental decisions on terminating or continuing a pregnancy. Further experience will be required before we know the limits of accuracy in prediction of severity; in early termination after first trimester diagnosis it is rarely feasible to analyse muscle for signs of disease, while the immature appearance of muscle in congenitally affected patients would in any case make findings difficult to interpret in a fetal sample.
All the families with affected pregnancies in this series illustrate the phenomenon of anticipation, showing progressively earlier onset and greater severity in successive generations." This can now be explained in terms of progressive DNA expansion, as shown in figs 1 and 4, though it is likely that an additional maternal factor is also operating in the congenital form of the disease.
The pregnancies in this series found to be normal are currently continuing. Where linked markers could also be applied (families 2 and 5) these predicted a low risk. In family 2 the mother had previously had two congenitally affected children, making it likely that, had this fetus been affected, it too would have been severely affected and would have shown a large DNA expansion comparable to that of the previous child (fig 2) , whereas in fact a normal 9 kb band pattern was seen.
One fetus predicted to be unaffected had an affected father (fig 3) and was thus not at risk of being congenitally affected. Again no abnormal band was seen, the pregnancy showing a normal heterozygous pattern with both a 9 kb and 1O kb band. This pattern allows a confident prediction of normality since it can be seen that the 9 kb band has been received from the affected father and the 10 kb band from the normal mother; invariably the myotonic dystrophy mutation is present on chromosomes with the 10 kb allele.
In none of the pregnancies was an accurate determination of copy number of the repeat sequence made using PCR based analysis. Normal subjects have been shown to have up to 30 copies of the CTG repeat sequence, while in minimally affected patients with myotonic dystrophy over 50 copies are present.'0 Large expansions are not detectable by PCR which would thus have been unhelpful in the detection of the large or moderate DNA expansion expected and found in the abnormal cases described here. Minimally affected sibs of congenital cases are exceptional,'2 and in both paternal and maternal transmission expansion of the unstable CTG repeat sequence is much more common than reduction in size, though we have occasionally observed the latter (Harley et al, in preparation). It seems likely that Southern blotting will detect almost all clinically significant cases of myotonic dystrophy. In minimally affected older patients with myotonic dystrophy the DNA expansion may be difficult to distinguish from the normal lOkb allele using EcoRI and in such circumstances it can be more easily seen using probe pM1OM6 with a PstI digest. Small expansions of 100bp upwards can be seen using this method although larger expansions may be difficult to assess accurately owing to smearing of the band which results from somatic instability. For detecting large expansions, which would usually be expected during prenatal diagnosis, an EcoRI digest is preferable.
The implication of detecting a minimal expansion should be discussed in genetic counselling before testing. most families requesting prenatal diagnosis are concerned with the avoidance of clinically significant disease in a child, especially of congenital or severe childhood onset.
In all the families studied here, DNA was available for testing from one or more affected family members to ensure that a detectable specific DNA expansion was present in the family. The importance of such analysis should be emphasised, since it is still possible that occasional cases of the disease may prove to have a different mutational basis.
Finally, it should be remembered that closely linked DNA markers have provided a means of prenatal diagnosis for some years45 and it would seem wise to continue to use these as a check on results until experience with analysis of the specific mutation is greater. However, it seems likely that in the future, the specific mutational approach described here will supersede linkage in view of its applicability to all families, regardless of pedigree structure, the avoidance of error from recombination and need for computational analyses, as well as the information that it seems likely to give regarding severity of phenotype. A close parallel can be seen with the diagnostic use of the fragile X unstable DNA sequence, which is also proving of wide application. '3 We thank the clinicians and laboratories who referred families, in particular Dr Ian Glass (Birmingham), Professor Mayana Zatz (Brazil), and Professor H Zakut (Israel). We also thank Dr Fiona MacDonald for undertaking analysis of linked markers in family 2. Our work is supported by grants from the Muscular Dystrophy Group of Great Britain, the Muscular Dystrophy Association of America, the Medical Research Council, and the Wellcome Trust.
